TP73 and hepatocellular carcinoma: Results showed that in all human HCC cell lines, expression levels of TP73-AS1 were upregulated compared to control group, among which TP73-AS1 were more significantly upregulated in HCCLM3 and HepG2 cells (Fig. 1d).